Communications Biology

Resveratrol reduced kidney scarring in mice with diabetes

In experiments in diabetic mice, resveratrol also reduced senescence, a state in which cells stop dividing.

Fig. 1. Resveratrol mitigates renal fibrosis in db/db chronic kidney disease mice model.
Open the figure at full size
Fig. 1. Resveratrol mitigates renal fibrosis in db/db chronic kidney disease mice model.Resveratrol mitigates renal fibrosis in db/db chronic kidney disease mice model.Li et al., CC BY
Studied:
Experiments in db/db mice with diabetic kidney disease, 8 weeks, against untreated diabetic mice
What changed:
Resveratrol-treated diabetic mice had less kidney scarring than untreated diabetic mice
The catch:
Kidney scarring was assessed after only 8 weeks of treatment
In the record:
One of 1,480 papers on resveratrol on record: 343 with results in people, 395 in animals. Its result on cellular senescence agrees with 29 of 30 other findings on record; 1 points the other way.

Editor of record: Boris Djordjevic · AgingResearch.News

Follow @agingbrief

Db/db mice given resveratrol had less kidney scarring and cellular senescence in an animal experiment on diabetic kidney disease. Resveratrol altered interactions between proteins that switch genes on or off.

In mouse kidney tubule cells, high-sugar conditions increased E2F1, a protein that activates gene activity. This caused DNA damage and senescence. Reducing E2f1 gene activity in mice also eased diabetic kidney disease. The authors reported that resveratrol increased E2F7 and E2F8, two proteins that suppress gene activity. These proteins bound to the control region of the E2f1 gene and reduced its activity, suppressing E2F1-induced senescence. The authors highlighted this regulatory relationship as a promising therapeutic target.

Why it matters

Cell senescence connects this work to an aging-related process. The authors identify control of gene activity as a potential route for targeting senescence in diabetic kidney disease.

Caveats

Experiments in mice and mouse kidney cells do not show whether resveratrol would reduce kidney damage in people with diabetes.

From the paper

Limitation

Notably, tubulointerstitial E2F1 expression exhibited an unexpected positive correlation with GFR within the DKD cohort.

Discussion

Quoted word for word from the full text on nature.com.

Comments

Be the first to comment.